These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33173335)

  • 1. Development and Validation of Nomograms for Predicting Cancer-Specific Survival in Elderly Patients with Intrahepatic Cholangiocarcinoma After Liver Resection: A Competing Risk Analysis.
    Wang T; Zhang J; Wang W; Yang X; Kong J; Shen S; Wang W
    Cancer Manag Res; 2020; 12():11015-11029. PubMed ID: 33173335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma.
    Wu X; Yu W; Petersen RH; Sheng H; Wang Y; Lv W; Hu J
    BMC Cancer; 2020 May; 20(1):429. PubMed ID: 32416716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma.
    Wang T; Wang W; Zhang J; Yang X; Shen S; Wang W
    Front Oncol; 2020; 10():598433. PubMed ID: 33363028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence Trend and Competing Risk Analysis of Patients With Intrahepatic Cholangiocarcinoma: A Population-Based Study.
    Xing H; Tan B; Yang C; Zhang M
    Front Med (Lausanne); 2022; 9():846276. PubMed ID: 35433765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
    He Q; Xiong Y; Xia P; Yang X; Yu Y; Chen Z
    Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102283. PubMed ID: 38219821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competing risk nomogram for predicting cancer-specific mortality in patients with non-melanoma skin cancer.
    Tang L; Zhang L; Zeng Y; Li Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8817-8827. PubMed ID: 37142808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis.
    Wang T; Kong J; Yang X; Shen S; Zhang M; Wang W
    J Surg Oncol; 2020 Mar; 121(3):524-537. PubMed ID: 31867746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Integrated Prediction of Clinical and Pathological Factors on the Prognosis of Intrahepatic Cholangiocarcinoma.
    Chen G; Li S; Xia A; Xing Y; Liang W
    Am Surg; 2024 Jun; 90(6):1481-1490. PubMed ID: 38549438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Myeloid Signature-Based Nomogram Predicts the Postoperative Recurrence of Intrahepatic Cholangiocarcinoma.
    Liang J; Zhou H; Huang XQ; Liu YF; Zhang L; He D; Cui Y; Guo J; Hu K; Wu C
    Front Mol Biosci; 2021; 8():742953. PubMed ID: 34722632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram predicting cancer-specific survival in elderly patients with stages I-III colon cancer.
    Zheng P; Lai C; Yang W; Guo J; Xiao S; Chen Z
    Scand J Gastroenterol; 2020 Feb; 55(2):202-208. PubMed ID: 32008420
    [No Abstract]   [Full Text] [Related]  

  • 11. Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.
    Liang Z; Zhang E; Duan L; Weygant N; An G; Hu B; Yao J
    Technol Cancer Res Treat; 2022; 21():15330338211068960. PubMed ID: 35179409
    [No Abstract]   [Full Text] [Related]  

  • 12. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.
    Zhang R; Li Q; Fu J; Jin Z; Su J; Zhang J; Chen C; Geng Z; Zhang D
    BMC Cancer; 2021 Feb; 21(1):112. PubMed ID: 33535978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.
    Hyder O; Marques H; Pulitano C; Marsh JW; Alexandrescu S; Bauer TW; Gamblin TC; Sotiropoulos GC; Paul A; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Popescu I; Gigot JF; Mentha G; Feng S; Pawlik TM
    JAMA Surg; 2014 May; 149(5):432-8. PubMed ID: 24599477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A competing-risk nomogram to predict cause-specific death in elderly patients with colorectal cancer after surgery (especially for colon cancer).
    Wang Z; Wang Y; Yang Y; Luo Y; Liu J; Xu Y; Liu X
    World J Surg Oncol; 2020 Feb; 18(1):30. PubMed ID: 32019568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a competing risk nomogram that predicts the survival of patients with a primary hepatic neuroendocrine tumor.
    Lin J; Li X; Ding X; Chen Z; Wu Y; Zhao K
    Front Med (Lausanne); 2022; 9():960235. PubMed ID: 36425110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting cancer-specific mortality in patients with parotid gland carcinoma by competing risk nomogram.
    Luo X; Liu S; Chen Y; Qiu X; Huang D; Zhang D; Liang Q; Yang Y; Zeng X
    Head Neck; 2021 Dec; 43(12):3888-3898. PubMed ID: 34632674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of sarcopenia combined with preoperative fibrinogen-albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study.
    Yu H; Wang M; Wang Y; Yang J; Deng L; Bao W; He B; Lin Z; Chen Z; Chen K; Zhang B; Liu F; Yu Z; Ye L; Jin B; Chen G
    Cancer Med; 2021 Jul; 10(14):4768-4780. PubMed ID: 34105304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and validation of a nomogram for predicting overall survival of node-negative perihilar cholangiocarcinoma.
    Huang XT; Cai JP; Chen W; Huang CS; Li JH; Gan TT; Liang LJ; Yin XY
    Asian J Surg; 2022 Feb; 45(2):712-717. PubMed ID: 34384677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multidimensional nomogram combining imaging features and clinical factors to predict the invasiveness and metastasis of combined hepatocellular cholangiocarcinoma.
    Wang Y; Zhou CW; Zhu GQ; Li N; Qian XL; Chong HH; Yang C; Zeng MS
    Ann Transl Med; 2021 Oct; 9(20):1518. PubMed ID: 34790724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
    Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
    Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.